Increasing incidence of prostate cancer in Taiwan-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Increasing incidence of prostate cancer in Taiwan

Published:2020-09-25 Issue:39 Volume:99 Page:e22336
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Lin Po-Hung,Chang Su-Wei,Tsai Ling-Hsuan,Kan Hung-Cheng,Liu Jui-Ming,Chuang Cheng-Keng,Pang See-Tong,Yu Kai-Jie

Funder

Chang Gung Medical Research Program

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference27 articles.

1. Cancer statistics, 2020;Siegel;CA A Cancer J Clin,2020

2. Prostate cancer epidemiology;Grönberg;Lancet,2003

3. Risk factors for prostate cancer;Gann;Rev Urol,2002

4. Global incidence and mortality for prostate cancer: analysis of temporal patterns and trends in 36 countries;Wong;Eur Urol,2016

5. Screening for prostate cancer starting at age 50–54 years. A Population-based cohort study;Carlsson;Eur Urol,2017

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world safety and effectiveness of radium‐223 in patients with metastatic castration‐resistant prostate cancer: Interim analyses of the prospective, observational RAPIT study;International Journal of Cancer;2024-06-26

2. Survival outcomes of radium-223 therapy for metastatic castration-resistant prostate cancer following national health insurance reimbursement in Taiwan;Journal of the Chinese Medical Association;2024-05-21

3. Prostate cancer management in Southeast Asian countries: a survey of clinical practice patterns;Therapeutic Advances in Medical Oncology;2024-01

4. EGFR‐mediated hyperacetylation of tubulin induced docetaxel resistance by downregulation of HDAC6 and upregulation of MCAK and PLK1 in prostate cancer cells;The Kaohsiung Journal of Medical Sciences;2023-11-02

5. Genetic variants of dipeptidyl peptidase IV are linked to the clinicopathologic development of prostate cancer;Journal of Cellular and Molecular Medicine;2023-08-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3